Dalton Pharma Services and The Henry M. Jackson Foundation Announce a Services Agreement for the Advancement of Military Medicine

October 5, 2011

Dalton Enters Into cGMP Vaccine and Conjugation Aseptic Fill Services Agreement with The Henry M. Jackson Foundation for the Advancement of Military Medicine

Toronto, Ontario (PRWEB) October 05, 2011

Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading pharmaceutical companies, today announced the company has entered into a Contract for Service with The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) to supply and provide sterile fill services for a cGMP grade capsule conjugate vaccine against Campylobacter jejuni developed by the Naval Medical Research Center (NMRC) and Prof. Mario Monteiro (University of Guelph).

Dalton will scale up the conjugation and purification process of a capsule-protein conjugate vaccine intended for use in Phase 1 human clinical trials conducted by NMRC.

âœOur expertise and capabilities in conjugation chemistry, sterile API manufacturing and our strength in aseptic filling, solidified the manufacturing agreement,” said Peter Pekos, President and CEO of Dalton. âœDalton is committed to supporting the efforts of the Navy and the University of Guelph for novel vaccine research and development.â

About Dalton:

Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada approved contract pharmaceutical manufacturer that supplies chemistry, analytical and formulation development services to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry and fine chemical manufacture. Dalton provides cGMP manufacturing of solid dosage forms and aseptic filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial). In its state of the art cGMP facilities, Dalton produces active pharmaceutical ingredients at the gram or kilogram scale. Dalton conducts aseptic fills to produce batches of finished drug product in vials or syringes, either aseptically filled or terminally sterilized, under fully validated conditions. In addition, Daltonâs analytical chemistry laboratory offers method development, validation and ICH stability programs to its clients. Further information can be found at http://www.dalton.com.

About HJF:

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. is a private, not-for-profit organization established in 1983 and authorized by Congress to support medical research and education at the Uniformed Services University of the Health Sciences and throughout the military medical community. Its research support and administrative capabilities allow military medical researchers and clinicians to maintain their scientific focus and to accomplish their goals in a timely and cost-effective manner. For more information, visit http://www.hjf.org.

About Prof. Monteiro:

Mario A. Monteiro is an Associate Professor in the Department of Chemistry at the University of Guelph. His groundbreaking research aims to protect both people and animals from serious disorders. He is developing sugar-based vaccines against gastric pathogens, such Campylobacter jejuni, which causes travellersâ diarrhea; Helicobacter pylori, which causes gastric cancer; and Clostridium difficile, which causes antibiotic-associated diarrhea. For more information, visit http://www.uoguelph.ca/~monteiro/.

# # #

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/10/prweb8843333.htm

Source: prweb

comments powered by Disqus